Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02287 |
| Species: | Mus musculus |
| Position : | chr15:79849001-79850000 |
| Year: | 2022 |
| Title: | A SOX17-PDGFB signaling axis regulates aortic root development |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 35831318 |
| MONDO: | |
| Tissue: | Aorta |
| Tissue Ontology ID: | UBERON:0000947 |
| Cell Source: | Cardiac endothelial cells (MCECs) |
| CVCL ID: | |
| Cell Type: | cardiac endothelial cell |
| Cell Ontology ID: | CL:0000115 |
| Experiment Type: | TF binding assay, Enhancer activity assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | ChIP-RT-qPCR, Luciferase Reporter Assay |
| Target gene : | Pdgfb |
| TF name : | Sox17 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Sox17 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| Sox17 | Wnt signaling pathway | kegg | 135 |
| Sox17 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |